|
CAS番号. | 862507-23-1 |
化学名: | |
别名: | |
英語化学名: | LY2228820 |
英語别名: | LY2228820;LY2228820 2MsOH;LY2228820 diMesylate;LY2228820(LY-2228820);5-(2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate;5-[2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-imidazo[4,5-b]pyridin-2-amine methanesulfonate;5-[2-(1,1-DiMethylethyl)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate |
CBNumber: | CB82518277 |
分子式: | C26H37FN6O6S2 |
分子量: | 612.7369832 |
MOL File: | 862507-23-1.mol |
|
|
|
|
LY2228820 化学特性,用途語,生産方法 |
使用
LY2228820 is a novel and potent p38MAPK inhibitor with potent antiinflammatory activity. LY2228820 significantly inhibited phosphorylation of MAPKAPK2 and/or HSP27, down stream targets of p38MAPK, in both multiple myeloma (MM) cell lines and LT-BMSCs. LY2228820 is a potential candidate to improve MM patient outcome both by enhancing the effect of Bortezomib (B675700) and by reducing osteoskeletal events. |
|
|
LY2228820 上流と下流の製品情報 |
原材料
|
準備製品
|
LY2228820 生産企業 Global( 21)Suppliers |
|
|
|
|
862507-23-1
LY2228820
5-[2-(1,1-DiMethylethyl)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate
LY2228820(LY-2228820)
LY2228820 2MsOH
LY2228820 diMesylate
5-[2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-imidazo[4,5-b]pyridin-2-amine methanesulfonate
5-(2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate
|